Abstract:Objecitve To explore the feasibility and value of clinical pathway management on parallel-track design for pediatric bronchopneumonia with rotavirus enteritis. Methods A total of 206 cases of pediatric bronchopneumonia with rotavirus enteritis treated from September 2017 to October 2018 were randomly divided into control group and observation group (n=103, each).The traditional clinical pathway method was adopted in control group, while the clinical pathway on parallel-track design was performed in observation group.The access rate, completion rate, hospitalization expenses and hospital stay were compared between two groups. Results The clinical access rate (92.23% vs 65.04%) and completion rate(78.64% vs 27.18%)in observation group were significantly higher than those in control group (P<0.01).The total hospitalization expense and the hospitalization time in observation group were significantly lower than those in control group (P<0.01), even though the average daily treatment cost was obviously higher than that in control group.The satisfaction degree of family member in observation group was significantly higher than that in control group(98.06% vs 88.35%, P<0.01). Conclusion The clinical access rate and completion rate of parallel-track design is higher and convenient for clinical operation in pediatric bronchopneumonia with rotavirus enteritis.Meanwhile, the patients have fewer days in hospital and lower total cost.